Abstract

We used exome sequencing to identify the genetic basis of combined malonic and methylmalonic aciduria (CMAMMA). We sequenced the exome of an individual with CMAMMA and followed up with sequencing of eight additional affected individuals (cases). This included one individual who was identified and diagnosed by searching an exome database. We identify mutations in ACSF3, encoding a putative methylmalonyl-CoA and malonyl-CoA synthetase as a cause of CMAMMA. We also examined a canine model of CMAMMA, which showed pathogenic mutations in a predicted ACSF3 ortholog. ACSF3 mutant alleles occur with a minor allele frequency of 0.0058 in 1,000 control individuals, predicting a CMAMMA population incidence of 1:30,000. ACSF3 deficiency is the first human disorder identified as caused by mutations in a gene encoding a member of the acyl-CoA synthetase family, a diverse group of evolutionarily conserved proteins, and may emerge as one of the more common human metabolic disorders.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Accessions

GenBank/EMBL/DDBJ

NCBI Reference Sequence

References

  1. 1.

    , , & Combined malonic and methylmalonic aciduria with normal malonyl-coenzyme A decarboxylase activity: a case supporting multiple aetiologies. J. Inherit. Metab. Dis. 21, 382–390 (1998).

  2. 2.

    et al. Methylmalonic and malonic aciduria in a dog with progressive encephalomyelopathy. Metab. Brain Dis. 11, 239–247 (1996).

  3. 3.

    et al. The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine. Genome Res. 19, 1665–1674 (2009).

  4. 4.

    , , & Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome. J. Lipid Res. 48, 2736–2750 (2007).

  5. 5.

    , , , & Mitochondrial fatty acid synthesis–an adopted set of enzymes making a pathway of major importance for the cellular metabolism. Prog. Lipid Res. 49, 27–45 (2010).

  6. 6.

    & A gene cluster encoding malonyl-CoA decarboxylase (MatA), malonyl-CoA synthetase (MatB) and a putative dicarboxylate carrier protein (MatC) in Rhizobium trifolii–cloning, sequencing, and expression of the enzymes in Escherichia coli. Eur. J. Biochem. 257, 395–402 (1998).

  7. 7.

    & Identification of active-site residues in Bradyrhizobium japonicum malonyl-coenzyme A synthetase. Arch. Biochem. Biophys. 378, 167–174 (2000).

  8. 8.

    , , & Mutational analysis of a fatty acyl-coenzyme A synthetase signature motif identifies seven amino acid residues that modulate fatty acid substrate specificity. J. Biol. Chem. 272, 4896–4903 (1997).

  9. 9.

    , , , & Mutational analysis of 4-coumarate:CoA ligase identifies functionally important amino acids and verifies its close relationship to other adenylate-forming enzymes. FEBS Lett. 467, 117–122 (2000).

  10. 10.

    , , & Fatty acid transport in Saccharomyces cerevisiae. Directed mutagenesis of FAT1 distinguishes the biochemical activities associated with Fat1p. J. Biol. Chem. 277, 31062–31071 (2002).

  11. 11.

    et al. Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program. J. Pediatr. 134, 675–680 (1999).

  12. 12.

    et al. Systematic comparison of three genomic enrichment methods for massively parallel DNA sequencing. Genome Res. 20, 1420–1431 (2010).

  13. 13.

    et al. Propionyl-CoA and adenosylcobalamin metabolism in Caenorhabditis elegans: evidence for a role of methylmalonyl-CoA epimerase in intermediary metabolism. Mol. Genet. Metab. 89, 64–73 (2006).

Download references

Acknowledgements

We thank the subjects and families for participating, E. Ostrander for the gift of unrelated Labrador DNA samples, K.M. Gibson and R. Wander for performing the malonyl-CoA decarboxylase assay on fibroblasts from subjects 2 and 9, J. Teer for bioinformatics assistance, S. Suchy for subject referral, M. Podell and W. Gahl for helpful discussions, R. Fisher, I. Bernardini, A. Gropman, L. Hecht, F. Facio, C. Gitiaux, C. Ottolenghi, D. Rabier and G. Touati for laboratory assistance and clinical care, and M. Oglesbee and A. Genders for searching for dogs related to the affected Labrador retriever. J.L.S., J.J.J., I.M., R.J.C., N.C.-C., S.D.C., J.R.S., H.M.D., M.H., K.O., N.S.H., J.C.S., C.K., L.G.B. and C.P.V. were supported by the Intramural Research Program of the NHGRI, NIH. M.D.G. was supported by NIA K23 AG021989 and R01-AG031189.

Author information

Author notes

    • Jennifer L Sloan
    •  & Jennifer J Johnston

    These authors contributed equally to this work.

Affiliations

  1. Genetics and Molecular Biology Branch, National Human Genome Research Institute (NHGRI), US National Institutes of Health (NIH), Bethesda, Maryland, USA.

    • Jennifer L Sloan
    • , Irini Manoli
    • , Randy J Chandler
    • , Nuria Carrillo-Carrasco
    • , Suma D Chandrasekaran
    • , Justin R Sysol
    • , Natalie S Hauser
    •  & Charles P Venditti
  2. Genetic Disease Research Branch, NHGRI, NIH, Bethesda, Maryland, USA.

    • Jennifer J Johnston
    • , Caitlin Krause
    • , Julie C Sapp
    •  & Leslie G Biesecker
  3. Department of Pharmacology, Institute for Biomedical Sciences, George Washington University, Washington, DC, USA.

    • Randy J Chandler
  4. Medical Genetics Branch, NHGRI, NIH, Bethesda, Maryland, USA.

    • Kevin O'Brien
    • , Heidi M Dorward
    •  & Marjan Huizing
  5. Department of Pediatrics, Biochemical Genetics Laboratory, University of California, San Diego, La Jolla, California, USA.

    • Bruce A Barshop
    •  & William L Nyhan
  6. Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.

    • Susan A Berry
  7. Department of Pediatrics, Harvard Medical School, Children's Hospital Boston, Boston, Massachusetts, USA.

    • Philip M James
  8. Greenwood Genetics Center, Greenwood, South Carolina, USA.

    • Neena L Champaigne
  9. Reference Center for Inherited Metabolic Disorders, Necker-Enfants Malades Hospital, Paris, France.

    • Pascale de Lonlay
    •  & Vassilli Valayannopoulos
  10. Department of Neurology, University of California, San Francisco, San Francisco, California, USA.

    • Michael D Geschwind
  11. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

    • Dimitar K Gavrilov

Consortia

  1. NIH Intramural Sequencing Center Group

    NIH Intramural Sequencing Center Group

Authors

  1. Search for Jennifer L Sloan in:

  2. Search for Jennifer J Johnston in:

  3. Search for Irini Manoli in:

  4. Search for Randy J Chandler in:

  5. Search for Caitlin Krause in:

  6. Search for Nuria Carrillo-Carrasco in:

  7. Search for Suma D Chandrasekaran in:

  8. Search for Justin R Sysol in:

  9. Search for Kevin O'Brien in:

  10. Search for Natalie S Hauser in:

  11. Search for Julie C Sapp in:

  12. Search for Heidi M Dorward in:

  13. Search for Marjan Huizing in:

  14. Search for Bruce A Barshop in:

  15. Search for Susan A Berry in:

  16. Search for Philip M James in:

  17. Search for Neena L Champaigne in:

  18. Search for Pascale de Lonlay in:

  19. Search for Vassilli Valayannopoulos in:

  20. Search for Michael D Geschwind in:

  21. Search for Dimitar K Gavrilov in:

  22. Search for William L Nyhan in:

  23. Search for Leslie G Biesecker in:

  24. Search for Charles P Venditti in:

Contributions

J.C.S. and L.G.B. developed the exome sequencing protocol. J.L.S., I.M., J.C.S., L.G.B. and C.P.V. designed the clinical research studies. The NIH Intramural Sequencing Center Group (N.I.S.C.G.) performed exome sequencing. J.J.J., J.L.S., I.M., R.J.C., L.G.B. and C.P.V. performed bioinformatic analyses. J.J.J. and C.K. performed mutational analysis and genotyping. R.J.C., N.C.-C., S.D.C. and J.R.S. performed cell culture studies and protein blot analyses. R.J.C. created viral vectors and performed cellular complementation studies. J.L.S., M.H. and H.M.D. performed immunofluorescence experiments. J.L.S., J.R.S. and I.M. performed enzymatic assays. J.L.S., I.M., N.S.H., K.O., J.C.S., B.A.B., S.A.B., P.M.J., N.L.C., P.d.L., V.V., M.D.G., W.L.N., L.G.B. and C.P.V. contributed to clinical evaluations and the delineation of the subject phenotypes. D.K.G. performed organic acid measurements. J.L.S., J.J.J., L.G.B. and C.P.V. prepared the manuscript. L.G.B. and C.P.V. conceived of and supervised the study.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Leslie G Biesecker.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figures 1–4 and Supplementary Tables 1–3.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/ng.908

Further reading